Related Experiment Video
Updated: Jun 23, 2026
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Off-Label Treatment of Alopecia Areata-Retrospective Study
Julia Sternicka-Rohde1,2, Leszek Bieniaszewski3, Natalia Krzyżaniak1
1Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Alopecia areata management heavily relies on off-label drug treatments, particularly glucocorticosteroids, in European clinical practice. This study highlights the widespread use of these therapies due to limited approved options for this autoimmune disorder.
Area of Science:
- Dermatology
- Autoimmune Disorders
- Pharmacology
Background:
- Alopecia areata is a prevalent autoimmune disorder impacting quality of life.
- Limited approved treatments necessitate off-label pharmacotherapy.
- Understanding real-world treatment patterns is crucial.
Purpose of the Study:
- To characterize the epidemiological profile of alopecia areata patients.
- To analyze real-world treatment patterns for alopecia areata.
- To assess the utilization of off-label pharmacotherapy.
Main Methods:
- Retrospective analysis of electronic medical records.
- Study conducted at University Clinical Centre in Gdańsk (2014-2024).
- Inclusion of 334 patients with alopecia areata.
Main Results:
- Women were more frequently affected and older at diagnosis than men in isolated cases.
- Off-label pharmacotherapy was used in 77.9% of all patients.
- Glucocorticosteroids were the most common off-label agents (65.3%), often as monotherapy.
Conclusions:
- Real-world alopecia areata management in Europe shows extensive reliance on off-label therapies.
- Topical and systemic glucocorticosteroids are frequently used.
- Further research into effective, approved treatments is warranted.
More Related Videos
03:22Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
